Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
MicroRNA-203a-3p as a Modulator of Doxorubicin Resistance in Hepatocellular Carcinoma: Molecular and Metabolic Insights
Hepatocellular carcinoma (HCC) continues to be a significant global health concern, ranking third in mortality rates among all cancer types. Despite therapeutic advancements, doxorubicin (DOX) remains a cornerstone chemotherapeutic agent in the treatment of HCC. However, its efficacy is often limite...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Published: |
AUC Knowledge Fountain
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: MicroRNA-203a-3p as a Modulator of Doxorubicin Resistance in Hepatocellular Carcinoma: Molecular and Metabolic Insights
- Expression Levels of miR-590-3p in Hepatocellular Carcinoma and Osteosarcoma Cell Lines and its Downstream Target Genes
- Knockdown of MDM2 in HepG2 Cell Line: A Step Towards Understanding the Relation Between miRNA590-3p and its Downstream Target Gene, MDM2, in Hepatocellular Carcinoma
- The Role of Non-coding RNAs as an Innovative Therapeutic Tool for Hepatocellular Carcinoma
- Comparing the protective effects of Resveratrol, Curcumin, and Sulforaphane against Doxorubicin-mediated inflammation in macrophages
- Cytotoxic Activity of Salvia Officinalis Extract Mediated by the Inhibition of JAK2 in Breast Cancer
- MiR-590-3p suppresses cellular migration and clonogenicity and epithelial to mesenchymal transition in the HepG2 cell line by targeting MDM2 and SETD7